Eli Lilly And Co vs Teucrium Soybean Fund — how do they compare? Eli Lilly And Co trades at $1,219.85 (market cap $1.08T), while Teucrium Soybean Fund trades at $25.05. The key difference: Eli Lilly And Co pays a 0.57% dividend while Teucrium Soybean Fund pays none. Which is the better fit depends on your goals.
| LLY | SOYB | |
|---|---|---|
Market Cap | $1.08T | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $1.24K | $26.28 |
52-Week Low | $639.43 | $21.46 |
Enterprise Value | $1.13T | — |
Dividend Yield | 0.57% | — |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,221.21, down 0.84% today, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The stock shows technical strength with bullish moving averages and support at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 48% revenue growth in Q2 2026. Recent news highlights the company's aggressive protection of its obesity drug pipeline against black market sales.
LLY presents a compelling growth story with dominant market positioning in weight-loss drugs and strong analyst support (73% buy ratings). Key risks include regulatory scrutiny and competitive pressures, but the company's raised guidance and pipeline advancements support continued upside toward the $1,380 consensus target.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →